| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |